|
|
Volumn 82, Issue 1-2, 2001, Pages 133-140
|
|
Therapeutic vaccination
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
DNA VACCINE;
GAMMA INTERFERON;
GENHEVAC;
HEPATITIS B ANTIBODY;
HEPATITIS B ANTIGEN;
HEPATITIS B VACCINE;
LAMIVUDINE;
LIVE VACCINE;
THYMOSIN ALPHA1;
ANTIBODY TITER;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CYTOKINE PRODUCTION;
CYTOTOXIC T LYMPHOCYTE;
DISEASE SEVERITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
HEPATITIS B VIRUS;
HERPES SIMPLEX VIRUS;
HUMAN;
IMMUNE RESPONSE;
IMMUNOMODULATION;
IMMUNOTHERAPY;
LATENT VIRUS INFECTION;
LIVER CELL CARCINOMA;
PRIORITY JOURNAL;
SEROCONVERSION;
SHORT SURVEY;
TH1 CELL;
VACCINATION;
VIRUS CARRIER;
VIRUS CELL INTERACTION;
VIRUS INFECTION;
VIRUS MUTATION;
VIRUS TRANSMISSION;
WART VIRUS;
HEPATITIS B VIRUS;
HUMAN PAPILLOMAVIRUS TYPES;
SIMPLEXVIRUS;
|
|
EID: 0037196594
PISSN: 01681702
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-1702(01)00395-1 Document Type: Review |
|
Times cited : (4)
|
|
References (0)
|
